Clin2
NCT04992624Possibly a fitRecruiting

Cannabinoid treatment effects on knee pain and nerve signals

Osteoarthritis, KneeOsteoarthritis of the Knee

Treatments studied

Part of Bones, joints & muscles clinical trials.

This Phase 2 study tests whether a cannabinoid-related treatment changes how pain works in people with knee osteoarthritis. It uses questionnaires, MRI, and gentle nerve testing to understand if treatment helps pain and pain-related signals.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
21 years to 75 years
Study type
Interventional

Who can take part

  • You have a provider-confirmed diagnosis of knee osteoarthritis
  • Your knee pain has been moderate to severe for at least 6 months
  • You have not used cannabis or CBD (in any form) in the past month
  • You can read and speak English for consent and questionnaires
  • You can safely do MRI and lie still on your back for 1–1.5 hours
  • You’re willing to pause certain pain meds and substances before testing (details below)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06234631Recruiting· Phase 2
CBD to reduce opioids after knee replacement

This study tests if a daily CBD capsule can help reduce the need for opioid pain pills after a first-time total knee replacement. It is for people with osteoarthritis who are having surgery and are willing to avoid cannabis for a short time before and after.

Ann Arbor, Michigan
NCT06414473Recruiting· Phase 1/Phase 2
CBD for knee osteoarthritis pain

This study tests whether a CBD (cannabidiol) product can help reduce pain and improve daily life for people with knee osteoarthritis. If you have moderate to severe knee pain and haven't used cannabis recently, you may be able to join.

Gainesville, Florida
NCT05454566Not yet recruiting· Phase 1/Phase 2
Study testing a new medicine for knee osteoarthritis pain

This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.

NCT07641517Recruiting· Phase 2
Testing LY4065967 for chronic knee osteoarthritis pain

This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.

Birmingham, Alabama
NCT06878417Recruiting
Cannabinoids for osteoarthritis knee or hip pain

This study tests if cannabinoid medications can reduce pain interference in daily life for people with hip or knee osteoarthritis. It may be a new option for moderate to severe pain.

Toronto, Ontario
NCT05020028Recruiting· Phase 2/Phase 3
CBD to reduce knee pain from osteoarthritis

This study tests cannabidiol (CBD) to help lower pain from knee osteoarthritis. It may be an option if you have ongoing knee pain and meet age, safety, and medication guidelines.

New York, New York

Hear when a new Osteoarthritis, Knee trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.